Fintel reports that on November 3, 2025, Baird maintained coverage of AptarGroup (NYSE:ATR) with a Outperform recommendation.

Fintel reports that on November 3, 2025, Wells Fargo maintained coverage of AptarGroup (NYSE:ATR) with a Overweight ...

AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool.

Shares of Archer Aviation are trading lower Monday afternoon, seeing a pullback despite a series of positive announcements in ...

AptarGroup stock faces a 25% drop and growth headwinds, but valuation is improving. Learn if ATR offers a compelling ...

When markets have been idling for an extended period of time, a good dose of increased volatility is what is needed to shake ...

AptarGroup Inc (ATR) reports a 6% sales growth and a dividend increase, while addressing challenges in its beauty and consumer healthcare segments.

Get key insights from AptarGroup’s Q3 2025 earnings call—injectables growth, Brazil expansion, and 2026 margin headwinds. See what’s next for ATR.

AptarGroup (ATR) delivered earnings and revenue surprises of +3.18% and +0.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

BAN’s release alleges that large U.S. brokers posing as recyclers are exporting electronic waste to developing countries, estimating roughly 2,000 export containers per month and identifying Malaysia ...